Literature DB >> 10659116

Octreotide as an agent for the relief of malignant ascites in palliative care patients.

W Cairns1, R Malone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10659116     DOI： 10.1191/026921699677473561

Source DB:  PubMed          Journal:  Palliat Med        ISSN： 0269-2163            Impact factor:   4.762


× No keyword cloud information.
  8 in total

1.  Palliative treatment of malignant ascites: profile of catumaxomab.

Authors:  Lila Ammouri; Eric E Prommer
Journal:  Biologics       Date:  2010-05-25

2.  The use of octreotide to manage symptoms of bronchorrhea: a case report.

Authors:  Meera Pahuja; Ray W Shepherd; Laurel J Lyckholm
Journal:  J Pain Symptom Manage       Date:  2013-09-12       Impact factor: 3.612

Review 3.  Treatment of malignant ascites.

Authors:  Michael Chung; Peter Kozuch
Journal:  Curr Treat Options Oncol       Date:  2008-09-06

4.  [Methods of symptom control in malignant ascites].

Authors:  Astrid Bodisch; Christian Muschitz; Meinolf Karthaus
Journal:  Wien Med Wochenschr       Date:  2008

5.  A pilot study of long-acting octreotide for symptomatic malignant ascites.

Authors:  Aminah Jatoi; Jorge J Nieva; Rui Qin; Charles L Loprinzi; Edward J Wos; Paul J Novotny; Dennis F Moore; Rex B Mowat; Naftali Bechar; Eduardo R Pajon; Lynn C Hartmann
Journal:  Oncology       Date:  2012-05-10       Impact factor: 2.935

Review 6.  Established and potential therapeutic applications of octreotide in palliative care.

Authors:  Eric E Prommer
Journal:  Support Care Cancer       Date:  2008-02-07       Impact factor: 3.603

Review 7.  Management of ascites due to gastrointestinal malignancy.

Authors:  Muhammad W Saif; Imran A P Siddiqui; Muhammad A Sohail
Journal:  Ann Saudi Med       Date:  2009 Sep-Oct       Impact factor: 1.526

8.  Ascites Index - an attempt to objectify the assessment of ascites.

Authors:  Piotr Szkodziak; Piotr Czuczwar; Krzysztof Pyra; Filip Szkodziak; Tomasz Paszkowski; Hugo Rio Tinto; Sławomir Woźniak
Journal:  J Ultrason       Date:  2018
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.